Atrovastatin Calcium 10mg, Fenofibrate 160mg, Ezetimibe IP 10mg
In the fight against cardiovascular disease, managing lipid levels effectively is critical. ATOVASTRIN EZ F is a unique combination formulation that brings together three powerful lipid-lowering agents: Atorvastatin Calcium 10mg, Fenofibrate (160mg), and Ezetimibe IP (10mg). This synergistic blend is specially formulated for patients who require intensive lipid control beyond what monotherapy can offer.
By combining a statin, a fibrate, and a cholesterol absorption inhibitor, ATOVASTRIN EZ F provides comprehensive management of both LDL (bad cholesterol) and triglycerides while improving HDL (good cholesterol), helping to significantly reduce the risk of atherosclerosis, heart attacks, and strokes.
Key Features and Ingredients
Atorvastatin Calcium (10mg)
A statin that works by inhibiting HMG-CoA reductase, reducing cholesterol synthesis in the liver and lowering LDL cholesterol levels.Fenofibrate (160mg)
A fibrate that activates peroxisome proliferator-activated receptor alpha (PPARα), enhancing the breakdown of triglycerides and increasing HDL cholesterol.Ezetimibe IP (10mg)
A cholesterol absorption inhibitor that blocks the absorption of dietary and biliary cholesterol in the intestine.
These three agents together make ATOVASTRIN EZ F a powerful choice in managing mixed dyslipidemia, especially in patients with metabolic syndrome or diabetes.
Usage
ATOVASTRIN EZ F is prescribed to:
Treat primary hypercholesterolemia or mixed dyslipidemia
Lower LDL-C (low-density lipoprotein cholesterol) and triglycerides
Raise HDL-C (high-density lipoprotein cholesterol)
Prevent cardiovascular events in high-risk patients
The combination is especially beneficial for patients who are not adequately controlled with statin monotherapy or who require enhanced triglyceride reduction.
How Does It Work?
Atorvastatin Calcium reduces cholesterol production in the liver, lowering circulating LDL-C.
Fenofibrate promotes the catabolism of triglyceride-rich lipoproteins and raises HDL-C.
Ezetimibe inhibits the intestinal absorption of cholesterol, reducing overall cholesterol levels entering the bloodstream.
Together, these mechanisms offer a comprehensive lipid-lowering effect, targeting multiple pathways of cholesterol and triglyceride metabolism.
Key Benefits
Reduces LDL-C effectively
Helps lower bad cholesterol significantly, reducing the risk of atherosclerosis and related complications.Controls Triglyceride Levels
Fenofibrate works to lower elevated triglycerides, which are a key risk factor for pancreatitis and cardiovascular disease.Increases HDL-C
Raises good cholesterol, which plays a protective role in cardiovascular health.Dual-site Action on Cholesterol
Ezetimibe complements Atorvastatin by preventing cholesterol absorption in the gut, creating a dual mechanism of action.Improves Outcomes in High-Risk Patients
Beneficial in patients with diabetes, metabolic syndrome, or existing cardiovascular disease who require aggressive lipid management.
Directions for Use
Take ATOVASTRIN EZ F once daily, preferably in the evening, with or without food.
Follow your physician’s prescribed dosage and do not alter or skip doses.
Maintain a heart-healthy diet, regular exercise routine, and monitor lipid levels regularly.
Side Effects
Common side effects may include:
Headache
Muscle pain or weakness
Gastrointestinal discomfort (nausea, indigestion)
Elevated liver enzymes
Increased blood sugar levels in diabetic patients
Rare but serious effects can include rhabdomyolysis, liver dysfunction, or allergic reactions. Patients should report any unusual muscle pain or fatigue to their doctor immediately.
Conclusion
ATOVASTRIN EZ F, containing Atorvastatin Calcium, Fenofibrate, and Ezetimibe tablets, is a scientifically balanced therapy for managing complex lipid disorders. It targets cholesterol production, absorption, and triglyceride breakdown, delivering a triple-benefit strategy in cardiovascular risk reduction.
About The Company
Steris Healthcare Pvt Ltd, widely recognized as Sterispharma, was established in February 2018 by a team of seasoned experts from the pharmaceutical sector. Based in Navi Mumbai, the company is proudly certified by WHO, GMP, and ISO, underscoring its unwavering commitment to quality and patient safety. Sterispharma is driven by a mission to make affordable, premium-quality medicines accessible throughout India, adhering strictly to WHO-recommended standards. Through its user-friendly online pharmacy platforms, customers can effortlessly order medications with home delivery services.
Sterispharma boasts an extensive portfolio of healthcare solutions, ranging from treatments for rare diseases to essential everyday healthcare needs. Their comprehensive product lineup addresses multiple therapeutic areas including Cardiology, Asthma, Respiratory Disorders, Nasal Care, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infective/Antibiotic Therapy, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. Medications are easily available for online purchase through their official websites — Sterisonline, Sterisindia, and Sterispharma — offering a seamless and reliable healthcare experience.
For further information
Email: info@sterispharma.com / contact@sterispharma.com
Call/WhatsApp: 8209542042 , 8824175417
